Crisis of Ebola virus disease in Democratic Republic of the Congo, A call to action
Samson Hangi, Aymar Akilimali(Roslin Institute), Hugues Cakwira(Green Circle), Styves Banga(Green Circle), Chrispin Biamba(University of Goma), Hardy Elembwe(University of Goma), Jospin Bisimwa(Université Evangélique en Afrique), Balagizi Ganywamulume, Priyadarshini Bhattacharjee, Leonard Sironge(Université Officielle de Bukavu)
Cited by 1
Related Papers
Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease
|Annals of Medicine and Surgery|2024|87
Revolutionary breakthrough: FDA approves Vyjuvek, the first topical gene therapy for dystrophic epidermolysis bullosa
|Annals of Medicine and Surgery|2023|30
Self-medication and Anti-malarial Drug Resistance in the Democratic Republic of the Congo (DRC): A silent threat
|Tropical Medicine and Health|2022|29
Barriers Encountered Toward Pursuing a Neurosurgical Career: A Cross-Sectional Study Among Medical Students, Interns, and Junior Doctors in Africa
|World Neurosurgery|2022|26
Global, regional, and national burden of Chagas disease, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
|The Lancet Infectious Diseases|2025|25